Search Results - Andrew F. Alexis
- Showing 1 - 7 results of 7
-
1
-
2
-
3
-
4
Efficacy and safety of fixed-dose clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel in Hispanic participants with moderate-to-severe acne: a pooled analysis by Valerie D. Callender, Hilary Baldwin, Linda Stein Gold, Fran E. Cook-Bolden, Eric Guenin, Andrew F. Alexis
Published in Journal of Dermatological Treatment (2025-12-01)Get full text
Article -
5
Predicting Abrocitinib Efficacy at Week 12 Based on Clinical Response at Week 4: A Post Hoc Analysis of Four Randomized Studies in Moderate-to-Severe Atopic Dermatitis by April W. Armstrong, Andrew F. Alexis, Andrew Blauvelt, Jonathan I. Silverberg, Claire Feeney, Mark Levenberg, Gary Chan, Fan Zhang, Luke Fostvedt
Published in Dermatology and Therapy (2024-06-01)Get full text
Article -
6
Tapinarof Cream for Adults and Children with Atopic Dermatitis—Efficacy by Race and Fitzpatrick Skin Type in Two Phase 3 Randomized Clinical Trials by Andrew F. Alexis, Leon Kircik, Raj Chovatiya, Zakiya P. Rice, Weily Soong, Tina Bhutani, Philip M. Brown, Stephen C. Piscitelli, David S. Rubenstein, Anna M. Tallman, April W. Armstrong
Published in Dermatology and Therapy (2025-07-01)Get full text
Article -
7
A Descriptive, Post Hoc Analysis of Efficacy and Safety of Risankizumab in Diverse Racial and Ethnic Patient Populations With Moderate-to-Severe Psoriasis by Andrew F. Alexis, Melinda Gooderham, Shawn G. Kwatra, Ahmad Amin, Susan Taylor, Ramon Espaillat, Trisha Rettig, Tianshuang Wu, Linyu Shi, Mark I. Kaldas, Deanne M. Dilley, Ranjeeta Sinvhal, Chudy Nduaka, Benjamin Lockshin
Published in Dermatology and Therapy (2024-10-01)Get full text
Article
